New medications that help individuals with type 2 diabetes gain control over their blood sugar have shown significant benefits in patients with heart failure with preserved ejection fraction (HFpEF).
To continue reading this article or issue you must be a paid subscriber. Sign in
Subscribe to Heart Advisor
Get the next year of Heart Advisor for just $20. And access all of our online content - over 2,000 articles - free of charge.
Subscribe today and save 38%. It's like getting 5 months FREE!
